EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

History of stroke as a predictor of high left atrial fibrosis in patients with persistent atrial fibrillation—insight from the DECAAF II randomized trial

Abdel Hadi El Hajjar, Lilas Dagher, Hadi Younes, Mario Mekhael, Charbel Noujaim, Nour Chouman, Tom Greene, Amitabh C Pandey, Chao Huang, Nassir Marrouche

Journal of Interventional Cardiac Electrophysiology · 2024

DOI: 10.1007/s10840-024-01837-4 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Interventional Cardiac Electrophysiology, 2024. Verfasst von Abdel Hadi El Hajjar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Tulane Research and Innovation for Arrhythmia Discoveries-TRIAD Center, Tulane University School of Medicine, New Orleans, LA, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Fibrosis, Stroke, Catheter Ablation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is a strong relationship between left atrial (LA) remodeling and ischemic stroke (IS) risk in atrial fibrillation (AF) patients. The Efficacy of Delayed Enhancement MRI-Guided Ablation vs. Conventional Catheter Ablation of Atrial Fibrillation (DECAAF-II) is the biggest MRI-based, randomized, multicenter clinical trial performed on persistent AF patients. The aim of this study is to evaluate the relationship between history of stroke and atrial fibrosis in the DECAAF II population.

Methods

Persistent AF patients who underwent Late Gadolinium Enhancement Magnetic Resonance Imaging (LGE-MRI) were included in the study and divided into two different groups: those with a history of stroke and those without. Propensity score matching was performed to adjust for covariates. Atrial fibrosis was compared in both groups. Then, patients were divided into different fibrosis groups, using three different cut-offs of baseline atrial fibrosis: ≥ 15%, ≥ 20%, and ≥ 25%. Univariate logistic regression and adjusted multivariate analysis were performed to assess the effect of clinical characteristics and risk factors on baseline fibrosis.

Results

Eight-hundred forty-three patients were recruited in DECAAF II, of whom 70 (8.3%) had a history of stroke. Patients with history of stroke had a higher prevalence of hypertension ( p = 0.043), diabetes ( p = 0.014), and hyperlipidemia ( p = 0.001). Seventy patients with no history of strokes were matched with patients with history of stroke to adjust for covariates using propensity score analysis. Patients in the stroke group had a significantly higher level of fibrosis than those without (20.2% vs. 8.1%, p = 0.017). Increased age was a significant predictor of all three baseline fibrosis classes (≥ 15%, ≥ 20%, and ≥ 25%). Additionally, history of stroke was found to be a predictor of baseline fibrosis ≥ 25% even after adjusting for other clinical characteristics and risk factors (OR = 1.98 [1.14–3.43], p = 0.01).

Conclusions

Left atrial fibrosis level greater than 25% correlates with the history of previous stroke episodes in patients with persistent atrial fibrillation. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationFibrosisStrokeCatheter AblationHumansFemaleMaleMiddle AgedAgedAtrial RemodelingHeart AtriaMagnetic Resonance ImagingRisk FactorsRisk AssessmentPropensity Score

Stichwörter der Autor:innen

Atrial fibrillationAtrial fibrosisStrokeStroke predictors

Autor:innen und Institutionen

  • Tulane Research and Innovation for Arrhythmia Discoveries-TRIAD Center, Tulane University School of Medicine, New Orleans, LA, USA.
  • Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Emory University School of Medicine, Atlanta, GA, USA.
  • Tulane Research and Innovation for Arrhythmia Discoveries-TRIAD Center, Tulane University School of Medicine, New Orleans, LA, USA. nmarrouche@tulane.edu.

Zitieren

APA

El Hajjar, A. H., Dagher, L., Younes, H., Mekhael, M., Noujaim, C., Chouman, N., Greene, T., Pandey, A. C., Huang, C., & Marrouche, N. (2024). History of stroke as a predictor of high left atrial fibrosis in patients with persistent atrial fibrillation—insight from the DECAAF II randomized trial. Journal of Interventional Cardiac Electrophysiology. https://doi.org/10.1007/s10840-024-01837-4

Vancouver

El Hajjar AH, Dagher L, Younes H, Mekhael M, Noujaim C, Chouman N, et al. History of stroke as a predictor of high left atrial fibrosis in patients with persistent atrial fibrillation—insight from the DECAAF II randomized trial. Journal of Interventional Cardiac Electrophysiology. 2024. doi:10.1007/s10840-024-01837-4

BibTeX
@article{ElHajjar2024,
  author = {El Hajjar, Abdel Hadi and Dagher, Lilas and Younes, Hadi and Mekhael, Mario and Noujaim, Charbel and Chouman, Nour and Greene, Tom and Pandey, Amitabh C and Huang, Chao and Marrouche, Nassir},
  title = {History of stroke as a predictor of high left atrial fibrosis in patients with persistent atrial fibrillation—insight from the DECAAF II randomized trial},
  journal = {Journal of Interventional Cardiac Electrophysiology},
  year = {2024},
  doi = {10.1007/s10840-024-01837-4}
}
Kostenlos starten →